Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earum Pharmaceuticals has informed that Ronak Lalwani has tendered his resignation on June 30, 2021 from the post of Company Secretary (CS) & Compliance Officer (CO) of the Company.
The above information is a part of company’s filings submitted to BSE.